EP1613732A4 - Complexes intracellulaires utilises comme biomarqueurs - Google Patents
Complexes intracellulaires utilises comme biomarqueursInfo
- Publication number
- EP1613732A4 EP1613732A4 EP20040758577 EP04758577A EP1613732A4 EP 1613732 A4 EP1613732 A4 EP 1613732A4 EP 20040758577 EP20040758577 EP 20040758577 EP 04758577 A EP04758577 A EP 04758577A EP 1613732 A4 EP1613732 A4 EP 1613732A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- biomarkers
- intracellular complexes
- intracellular
- complexes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/485—Epidermal growth factor [EGF] (urogastrone)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45988803P | 2003-04-01 | 2003-04-01 | |
US10/623,057 US7105308B2 (en) | 2002-07-25 | 2003-07-17 | Detecting receptor oligomerization |
US49448203P | 2003-08-11 | 2003-08-11 | |
US50803403P | 2003-10-01 | 2003-10-01 | |
US51294103P | 2003-10-20 | 2003-10-20 | |
US52325803P | 2003-11-18 | 2003-11-18 | |
PCT/US2004/009805 WO2004087887A2 (fr) | 2003-04-01 | 2004-03-30 | Complexes intracellulaires utilises comme biomarqueurs |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1613732A2 EP1613732A2 (fr) | 2006-01-11 |
EP1613732A4 true EP1613732A4 (fr) | 2012-03-14 |
Family
ID=33136354
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20040758577 Withdrawn EP1613732A4 (fr) | 2003-04-01 | 2004-03-30 | Complexes intracellulaires utilises comme biomarqueurs |
EP04759065A Withdrawn EP1613961A4 (fr) | 2003-04-01 | 2004-03-30 | Complexes de recepteurs de surface utilises comme biomarqueurs |
EP04759064.1A Expired - Lifetime EP1613205B1 (fr) | 2003-04-01 | 2004-03-30 | Complexes de recepteurs de surface erbb utilises comme biomarqueurs |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04759065A Withdrawn EP1613961A4 (fr) | 2003-04-01 | 2004-03-30 | Complexes de recepteurs de surface utilises comme biomarqueurs |
EP04759064.1A Expired - Lifetime EP1613205B1 (fr) | 2003-04-01 | 2004-03-30 | Complexes de recepteurs de surface erbb utilises comme biomarqueurs |
Country Status (6)
Country | Link |
---|---|
EP (3) | EP1613732A4 (fr) |
JP (2) | JP2006521821A (fr) |
AU (3) | AU2004229348A1 (fr) |
BR (3) | BRPI0408928A (fr) |
CA (3) | CA2521106A1 (fr) |
WO (3) | WO2004092353A2 (fr) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040229294A1 (en) | 2002-05-21 | 2004-11-18 | Po-Ying Chan-Hui | ErbB surface receptor complexes as biomarkers |
CA2521106A1 (fr) * | 2003-04-01 | 2004-10-14 | Monogram Biosciences, Inc. | Complexes intracellulaires utilises comme biomarqueurs |
BRPI0413471A (pt) | 2003-08-11 | 2006-10-17 | Monogram Biosciences Inc | métodos para detectar um ou mais complexos de proteìnas e para detectar um complexo em uma amostra biológica |
US7402399B2 (en) * | 2003-10-14 | 2008-07-22 | Monogram Biosciences, Inc. | Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy |
ATE520988T1 (de) * | 2004-09-22 | 2011-09-15 | Tripath Imaging Inc | Verfahren und zusammensetzungen zur bewertung einer brustkrebsprognose |
US7700299B2 (en) * | 2005-08-12 | 2010-04-20 | Hoffmann-La Roche Inc. | Method for predicting the response to a treatment |
AR056857A1 (es) | 2005-12-30 | 2007-10-24 | U3 Pharma Ag | Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos |
EP2008102A4 (fr) * | 2006-04-18 | 2009-07-08 | Wellstat Biologics Corp | Detection de proteines dans des cellules neoplastiques en circulation |
CA2663595A1 (fr) * | 2006-08-07 | 2008-02-14 | The Board Of Regents Of The University Of Texas System | Schemas proteomiques de pronostic du cancer et signatures predictives |
BRPI0717416A2 (pt) | 2006-09-21 | 2013-11-12 | Prometheus Lab Inc | Método para realizar um imunoensaio complexo de alta produtividade, e, arranjo |
WO2011008990A1 (fr) | 2009-07-15 | 2011-01-20 | Prometheus Laboratories Inc. | Sélection de médicaments pour la thérapie dun cancer gastrique au moyen de réseaux à base danticorps |
WO2008064884A1 (fr) | 2006-11-28 | 2008-06-05 | U3 Pharma Gmbh | Her3 activé servant de marqueur pour prédire l'efficacité thérapeutique |
EP2647388A1 (fr) | 2007-02-16 | 2013-10-09 | Merrimack Pharmaceuticals, Inc. | Anticorps dirigés contre l'ERBB3 et leurs utilisations |
JP5352585B2 (ja) * | 2007-07-13 | 2013-11-27 | ネステク ソシエテ アノニム | 抗体アレイを用いた肺癌治療のための薬剤選択 |
WO2009086197A1 (fr) | 2007-12-20 | 2009-07-09 | Monogram Biosciences, Inc. | Procédés de diagnostic du her-2 |
CN103399144B (zh) | 2008-02-25 | 2015-10-28 | 雀巢产品技术援助有限公司 | 用抗体阵列选择乳腺癌治疗药物 |
US8168755B2 (en) * | 2008-05-07 | 2012-05-01 | Eutropics Pharmaceuticals, Inc. | Antibodies specific to heterodimers of Bcl-2 family and uses thereof |
PE20120015A1 (es) * | 2008-08-15 | 2012-01-26 | Merrimack Pharmaceuticals Inc | Metodos y sistemas para predecir la respuesta de las celulas tumorales a un agente terapeutico |
SG177252A1 (en) | 2008-12-01 | 2012-03-29 | Lab Corp America Holdings | METHODS AND ASSAYS FOR MEASURING p95 AND/OR p95 IN A SAMPLE AND ANTIBODIES SPECIFIC FOR p95 |
WO2010083463A1 (fr) * | 2009-01-15 | 2010-07-22 | Laboratory Corporation Of America Holdings | Procédés de détermination d'une réponse de patient par la mesure de l'expression de her-2 |
EP2387711B1 (fr) | 2009-01-15 | 2015-04-22 | Laboratory Corporation of America Holdings | Procédés permettant de déterminer la réponse d'un patient par mesure de her-3 |
US20120100538A1 (en) | 2009-03-24 | 2012-04-26 | Biocept, Inc. | Devices and methods of cell capture and analysis |
JP5923035B2 (ja) | 2009-03-24 | 2016-05-24 | バイオセプト インコーポレイティッド | 細胞の捕捉および解析のデバイスおよび方法 |
CA2761777A1 (fr) | 2009-05-14 | 2010-11-18 | Prometheus Laboratories Inc. | Biomarqueurs permettant de determiner la sensibilite de cellules cancereuses du sein a un traitement ciblant le recepteur her2 |
CN105999263B (zh) | 2009-11-13 | 2021-06-29 | 第一三共欧洲有限公司 | 用于治疗或预防人表皮生长因子受体-3(her-3)相关疾病的材料和方法 |
DK2544680T3 (en) | 2010-03-11 | 2015-04-27 | Merrimack Pharmaceuticals Inc | USE OF ErbB3 INHIBITORS IN TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER |
US9719995B2 (en) | 2011-02-03 | 2017-08-01 | Pierian Holdings, Inc. | Drug selection for colorectal cancer therapy using receptor tyrosine kinase profiling |
WO2012135695A2 (fr) * | 2011-03-30 | 2012-10-04 | The Uab Research Foundation | Modulation de migration cellulaire |
ES2553456T3 (es) * | 2011-09-02 | 2015-12-09 | Nestec S.A. | Perfilado de proteínas de ruta de señal para determinar una eficacia terapéutica |
US20150150869A1 (en) | 2012-06-20 | 2015-06-04 | Eutropics Pharmaceuticals, Inc. | Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivatives |
US20160038503A1 (en) | 2012-11-21 | 2016-02-11 | David Richard | Methods and compositions useful for treating diseases involving bcl-2 family proteins with isoquinoline and quinoline derivatives |
US20160041171A1 (en) * | 2013-04-05 | 2016-02-11 | Laboratory Corporation Of America Holdings | Systems and methods for facilitating diagnosis, prognosis and treatment of cancer based on detection of her3 activation |
KR20160009070A (ko) * | 2013-05-21 | 2016-01-25 | 네스텍 소시에테아노님 | 대장암 환자의 생존율 예측 및 개선 방법 |
US10732182B2 (en) | 2013-08-01 | 2020-08-04 | Eutropics Pharmaceuticals, Inc. | Method for predicting cancer sensitivity |
US10640803B2 (en) | 2013-10-30 | 2020-05-05 | Eutropics Pharmaceuticals, Inc. | Methods for determining chemosensitivity and chemotoxicity |
WO2015100459A2 (fr) | 2013-12-27 | 2015-07-02 | Merrimack Pharmaceuticals, Inc. | Profils de biomarqueur pour prédire les résultats d'une thérapie cancéreuse utilisant des inhibiteurs d'erbb3 et/ou des chimiothérapies |
CN107406881B (zh) | 2015-01-12 | 2021-05-25 | 尤特罗皮克斯制药股份有限公司 | 用于指导癌症治疗的内容相关的诊断测试 |
US20190041389A1 (en) * | 2015-02-13 | 2019-02-07 | The University Of Queensland | Methods for classifying tumors and uses therefor |
US10184006B2 (en) | 2015-06-04 | 2019-01-22 | Merrimack Pharmaceuticals, Inc. | Biomarkers for predicting outcomes of cancer therapy with ErbB3 inhibitors |
EP3403095B1 (fr) | 2016-03-15 | 2019-08-07 | Laboratory Corporation of America Holdings | Procédés d'évaluation d'interactions de protéines entre des cellules |
EP3715844A4 (fr) * | 2017-11-20 | 2021-04-14 | Konica Minolta, Inc. | Procédé d'évaluation de médicament |
IT201800008274A1 (it) * | 2018-08-31 | 2020-03-02 | Alifax Srl | Metodo immunometrico per analisi cliniche biologiche |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995024205A1 (fr) * | 1994-03-07 | 1995-09-14 | New York University Medical Center | Procede et compositions de traitement du cancer du sein |
WO2003068808A1 (fr) * | 2002-02-13 | 2003-08-21 | Garvan Institute Of Medical Research | Nouveaux complexes proteiques et utilisations associees |
WO2003076649A1 (fr) * | 2002-03-05 | 2003-09-18 | Aclara Biosciences, Inc. | Analyse multiplex au moyen de sensibilisateurs fixes a une membrane |
WO2004091384A2 (fr) * | 2003-04-01 | 2004-10-28 | Monogram Biosciences, Inc. | Complexes de recepteurs de surface erbb utilises comme biomarqueurs |
WO2005037071A2 (fr) * | 2003-10-14 | 2005-04-28 | Monogram Biosciences, Inc. | Analyse de la voie de signalisation de la tyrosine kinase de recepteur pour diagnostic et therapie |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5597531A (en) | 1985-10-04 | 1997-01-28 | Immunivest Corporation | Resuspendable coated magnetic particles and stable magnetic particle suspensions |
US4795698A (en) | 1985-10-04 | 1989-01-03 | Immunicon Corporation | Magnetic-polymer particles |
JP3040121B2 (ja) | 1988-01-12 | 2000-05-08 | ジェネンテク,インコーポレイテッド | 増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法 |
US5183884A (en) | 1989-12-01 | 1993-02-02 | United States Of America | Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
DK0653066T3 (da) | 1992-07-31 | 1998-09-23 | Dade Behring Marburg Gmbh | Fotoaktiverbare kemiluminescerende matricer |
US5811098A (en) | 1992-11-24 | 1998-09-22 | Bristol-Myers Squibb Company | Antibodies to HER4, human receptor tyrosine kinase |
US5693271A (en) | 1994-09-01 | 1997-12-02 | Chase Industries, Inc. | Rotationally molding an insulated plastic molded door with integral hinge |
US5599631A (en) | 1995-03-08 | 1997-02-04 | Eastman Kodak Company | Fluorinated elastomer/fluorinated resin compositions for toner fusing members |
US5968511A (en) | 1996-03-27 | 1999-10-19 | Genentech, Inc. | ErbB3 antibodies |
US6417168B1 (en) * | 1998-03-04 | 2002-07-09 | The Trustees Of The University Of Pennsylvania | Compositions and methods of treating tumors |
US6095661A (en) | 1998-03-19 | 2000-08-01 | Ppt Vision, Inc. | Method and apparatus for an L.E.D. flashlight |
WO2000014105A1 (fr) * | 1998-09-08 | 2000-03-16 | Agouron Pharmaceuticals, Inc. | Modification de la proteine recepteur 2 de vegf et ses methodes d'utilisation |
US6627400B1 (en) | 1999-04-30 | 2003-09-30 | Aclara Biosciences, Inc. | Multiplexed measurement of membrane protein populations |
US6322980B1 (en) | 1999-04-30 | 2001-11-27 | Aclara Biosciences, Inc. | Single nucleotide detection using degradation of a fluorescent sequence |
US6514700B1 (en) | 1999-04-30 | 2003-02-04 | Aclara Biosciences, Inc. | Nucleic acid detection using degradation of a tagged sequence |
US6673550B2 (en) | 1999-04-30 | 2004-01-06 | Aclara Biosciences, Inc. | Electrophoretic tag reagents comprising fluorescent compounds |
US6346384B1 (en) | 2000-03-27 | 2002-02-12 | Dade Behring Inc. | Real-time monitoring of PCR using LOCI |
US7537938B2 (en) * | 2000-04-28 | 2009-05-26 | Monogram Biosciences, Inc. | Biomarker detection in circulating cells |
EP1305632B1 (fr) | 2000-05-04 | 2011-07-27 | Siemens Healthcare Diagnostics Products GmbH | Methodes servant a la detection d'analytes multiples |
US6547654B2 (en) | 2000-07-22 | 2003-04-15 | Americo Del Raso | Automatic abrasive sleeve tightening means and quick release system for an oscillating spindle sander |
US20020127654A1 (en) * | 2001-02-22 | 2002-09-12 | Price Virginia L. | Compositions and methods for production cell culture |
CZ20033143A3 (en) | 2001-05-21 | 2004-04-14 | Aclara Biosciences, Inc. | Methods and compositions for analyzing proteins |
AU2002316577A1 (en) | 2001-07-09 | 2003-01-29 | Aclara Biosciences, Inc. | Cell-screening assay and composition |
CA2354690A1 (fr) | 2001-07-20 | 2001-10-27 | Jan Prinzmetal | Tapis |
US6545102B1 (en) * | 2001-09-27 | 2003-04-08 | Lumigen, Inc. | Polymer-supported photosensitizers |
US7910314B2 (en) * | 2002-03-01 | 2011-03-22 | Roger Williams Hospital | Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer |
PL214010B1 (pl) * | 2002-07-15 | 2013-06-28 | Genentech Inc | Rekombinowane humanizowane przeciwcialo 2C4 i zastosowanie tego przeciwciala |
ATE442589T1 (de) | 2002-07-25 | 2009-09-15 | Aclara Biosciences Inc | Nachweis der rezeptoroligomerisierung |
-
2004
- 2004-03-30 CA CA002521106A patent/CA2521106A1/fr not_active Abandoned
- 2004-03-30 BR BRPI0408928-6A patent/BRPI0408928A/pt not_active IP Right Cessation
- 2004-03-30 AU AU2004229348A patent/AU2004229348A1/en not_active Abandoned
- 2004-03-30 JP JP2006509481A patent/JP2006521821A/ja active Pending
- 2004-03-30 CA CA002521082A patent/CA2521082A1/fr not_active Abandoned
- 2004-03-30 AU AU2004230700A patent/AU2004230700A1/en not_active Abandoned
- 2004-03-30 WO PCT/US2004/009717 patent/WO2004092353A2/fr active Application Filing
- 2004-03-30 EP EP20040758577 patent/EP1613732A4/fr not_active Withdrawn
- 2004-03-30 EP EP04759065A patent/EP1613961A4/fr not_active Withdrawn
- 2004-03-30 EP EP04759064.1A patent/EP1613205B1/fr not_active Expired - Lifetime
- 2004-03-30 WO PCT/US2004/009715 patent/WO2004091384A2/fr active Application Filing
- 2004-03-30 BR BRPI0408950-2A patent/BRPI0408950A/pt not_active IP Right Cessation
- 2004-03-30 CA CA002521077A patent/CA2521077A1/fr not_active Abandoned
- 2004-03-30 AU AU2004225439A patent/AU2004225439A1/en not_active Abandoned
- 2004-03-30 WO PCT/US2004/009805 patent/WO2004087887A2/fr active Application Filing
- 2004-03-30 JP JP2006509479A patent/JP2006523314A/ja active Pending
- 2004-03-30 BR BRPI0408961-8A patent/BRPI0408961A/pt not_active IP Right Cessation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995024205A1 (fr) * | 1994-03-07 | 1995-09-14 | New York University Medical Center | Procede et compositions de traitement du cancer du sein |
WO2003068808A1 (fr) * | 2002-02-13 | 2003-08-21 | Garvan Institute Of Medical Research | Nouveaux complexes proteiques et utilisations associees |
WO2003076649A1 (fr) * | 2002-03-05 | 2003-09-18 | Aclara Biosciences, Inc. | Analyse multiplex au moyen de sensibilisateurs fixes a une membrane |
WO2004091384A2 (fr) * | 2003-04-01 | 2004-10-28 | Monogram Biosciences, Inc. | Complexes de recepteurs de surface erbb utilises comme biomarqueurs |
WO2005037071A2 (fr) * | 2003-10-14 | 2005-04-28 | Monogram Biosciences, Inc. | Analyse de la voie de signalisation de la tyrosine kinase de recepteur pour diagnostic et therapie |
Non-Patent Citations (3)
Title |
---|
See also references of WO2004087887A2 * |
SHINODA SACHIKO ET AL: "Interaction of 14-3-3 with Bid during seizure-induced neuronal death.", JOURNAL OF NEUROCHEMISTRY, vol. 86, no. 2, July 2003 (2003-07-01), pages 460 - 469, XP002667074, ISSN: 0022-3042 * |
ZHA J ET AL: "Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL", CELL, CELL PRESS, US, vol. 87, 15 November 1996 (1996-11-15), pages 619 - 628, XP002110634, ISSN: 0092-8674, DOI: 10.1016/S0092-8674(00)81382-3 * |
Also Published As
Publication number | Publication date |
---|---|
BRPI0408961A (pt) | 2006-10-31 |
CA2521077A1 (fr) | 2004-10-28 |
WO2004091384A3 (fr) | 2005-12-29 |
EP1613961A4 (fr) | 2007-03-07 |
EP1613205B1 (fr) | 2013-04-24 |
AU2004230700A1 (en) | 2004-10-28 |
JP2006523314A (ja) | 2006-10-12 |
AU2004225439A1 (en) | 2004-10-14 |
CA2521106A1 (fr) | 2004-10-14 |
EP1613205A2 (fr) | 2006-01-11 |
BRPI0408928A (pt) | 2006-09-12 |
CA2521082A1 (fr) | 2004-10-28 |
WO2004092353A3 (fr) | 2005-03-03 |
AU2004229348A1 (en) | 2004-10-28 |
EP1613205A4 (fr) | 2006-11-29 |
BRPI0408950A (pt) | 2006-03-28 |
EP1613732A2 (fr) | 2006-01-11 |
WO2004092353A2 (fr) | 2004-10-28 |
WO2004087887A2 (fr) | 2004-10-14 |
EP1613961A2 (fr) | 2006-01-11 |
JP2006521821A (ja) | 2006-09-28 |
WO2004087887A3 (fr) | 2006-06-15 |
WO2004091384A2 (fr) | 2004-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1613732A4 (fr) | Complexes intracellulaires utilises comme biomarqueurs | |
IL174020A0 (en) | Antigen-scaffold complexes | |
DE602004023400D1 (en) | Lies | |
GB0322140D0 (en) | Combinations | |
ZA200602792B (en) | Multigame selection | |
DE502004011703D1 (en) | N-heterocyclyl-phenylsubstituierte cyclische ketoenole | |
GB0304515D0 (en) | Standard | |
HK1081463A1 (en) | Antineplastic combinations | |
TW568408U (en) | Slide structure | |
DE502004009243D1 (en) | Spirocyclische cyclohexan-derivate | |
ZA200703827B (en) | New pyridothlenopyrimidine derivates | |
DE502004006683D1 (en) | Injection-locked-oscillator-schaltkreis | |
DE502004003476D1 (en) | Standfuss | |
DE502004011852D1 (en) | Nspritzventil | |
DE502004004146D1 (en) | Pyrazolverbindungen | |
GB0311208D0 (en) | Feature based caricaturing | |
DE502004011343D1 (en) | Rotorspinnmaschine | |
DE502004012153D1 (en) | Rotorspinnmaschine | |
DE10394343D2 (en) | Berührungslose biometrische erkennung | |
AU155596S (en) | Case | |
IL174218A0 (en) | Ligands | |
EP1702851A4 (fr) | Tiroir a encoche | |
GB0313709D0 (en) | Ligands | |
GB0327016D0 (en) | Russell block | |
TW573910U (en) | Pivot |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20051026 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
PUAK | Availability of information related to the publication of the international search report |
Free format text: ORIGINAL CODE: 0009015 |
|
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 39/395 20060101AFI20060817BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20120210 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G01N 33/53 20060101AFI20120203BHEP Ipc: G01N 33/574 20060101ALI20120203BHEP Ipc: G01N 33/542 20060101ALI20120203BHEP |
|
17Q | First examination report despatched |
Effective date: 20150326 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20171003 |